Acuta Capital Partners, LLC Sangamo Therapeutics, Inc Transaction History
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
A detailed history of Acuta Capital Partners, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 740,000 shares of SGMO stock, worth $865,800. This represents 1.07% of its overall portfolio holdings.
Number of Shares
740,000Holding current value
$865,800% of portfolio
1.07%Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
134Shares Held
52.5MCall Options Held
1.02MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.37MShares$11 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.23MShares$10.8 Million0.05% of portfolio
-
State Street Corp Boston, MA5.02MShares$5.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$5.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$3.61 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $183M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...